Tao, Yong

Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents

Gao, X., Tao, Y., Lamas, V., Huang, M., Yeh, W.-H., Pan, B., Hu, Y.-J., Hu, J. H., Thompson, D. B., Shu, Y., et al. (2018) · Nature

Hearing, Cochlea, Tinnitus, GeneticsCRISPR and Genetic Engineering

Cited by 536

Epigenetic therapy inhibits metastases by disrupting premetastatic niches

Lu, Z., Zou, J., Li, S., Topper, M. J., Tao, Y., Zhang, H., Jiao, X., Xie, W., Kong, X., Vaz, M., et al. (2020) · Nature

Immune cells in cancerCancer Cells and Metastasis

Cited by 330

DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk

Xie, W., Kagiampakis, I., Pan, L., Zhang, Y. W., Murphy, L., Tao, Y., Kong, X., Kang, B., Xia, L., Carvalho, F. L. F., et al. (2018) · Cancer Cell

Epigenetics and DNA MethylationTelomeres, Telomerase, and Senescence

Cited by 122

Reliability and validity of the chinese (mandarin) tinnitus handicap inventory

Meng, Z., Zheng, Y., Liu, S., Wang, K., Kong, X., Tao, Y., Xu, K., & Liu, G. (2012) · Clinical and Experimental Otorhinolaryngology

Hearing, Cochlea, Tinnitus, GeneticsHearing Loss and Rehabilitation

Cited by 77